- Title: Subtitle
- A phase II study of tivozanib in patients with metastatic and non-resectable soft tissue sarcomas
- Creators
- Mark Agulnik - Northwestern UniversityMohammed M. Milhem - University of IowaAlfred Rademaker - Northwestern UniversityCatherine Humphreys - Northwestern UniversitySusan E. Abbinanti - Northwestern UniversityLauren Elizabeth Nye - Northwestern UniversityRasima Cehic - Northwestern UniversityAriel Polish - Northwestern UniversityClaudia Roxana Vintilescu - Northwestern UniversityThomas McFarland - UW Div of Hem/Onc, Madison, WIKeith M. Skubitz - University of MinnesotaSteven Ian Robinson - Mayo ClinicScott H. Okuno - Mayo ClinicBrian Andrew Van Tine - Washington University in St. Louis
- Resource Type
- Abstract
- Publication Details
- Journal of clinical oncology, Vol.33(15_suppl), pp.10515-10515
- DOI
- 10.1200/jco.2015.33.15_suppl.10515
- PMCID
- PMC6246191
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Language
- English
- Date published
- 05/20/2015
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984363176202771
Abstract
A phase II study of tivozanib in patients with metastatic and non-resectable soft tissue sarcomas
Journal of clinical oncology, Vol.33(15_suppl), pp.10515-10515
05/20/2015
DOI: 10.1200/jco.2015.33.15_suppl.10515
PMCID: PMC6246191
Details
Metrics
2 Record Views